
PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.

PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.
Founded: 2023
Headquarters: Cambridge / Boston, MA
Sector: AI/ML for clinical trial optimization (biopharma/CRO)
Customers: 30–45+ biopharma and CRO customers (company claims)
Funding: Series A on 2025-05-13; total funding reported ~$65M
Clinical trial design and operations optimization, subgroup/heterogeneous treatment effect analysis, adaptive and Bayesian trial implementation.
2023
Pharmaceutical Manufacturing
Seed round participation included Viola Ventures
Series A reported as led by Accel and Insight Partners
“Participation from Accel, Insight Partners, Exor Ventures, Viola Ventures, LionBird”
| Company |
|---|
About the Company
PhaseV is a fast-growing startup on a mission to reshape the future of clinical trials through the power of AI and machine learning. Our platform helps pharma and biotech companies design and run trials that are faster, more adaptive, and more successful. Backed by top-tier investors and trusted by a growing global client base, we're building a company that’s not just driving innovation but making a real impact on healthcare worldwide.
About the Role
We are looking for a hands-on, experienced Controller to join our finance team and take ownership of the company’s accounting operations and policies. This is a critical role for someone who thrives in a fast-paced startup environment and is eager to help scale our finance infrastructure while ensuring operational excellence.
In the early phase, the Controller will be deeply involved in day-to-day accounting execution and financial process development. As the company grows, the role will evolve to include strategic leadership and cross-functional collaboration.
Key Responsibilities (including but not limited to) :
Requirements
Must-Have:
Preferred Qualifications:
Location and Work Authorization
This role can be based in Tel Aviv, Israel, or Cambridge, MA and is hybrid, ideally.
*For candidates applying to the Cambridge office, a valid long-term (+2 years) U.S. work permit or existing work authorization is required.
Compensation and Benefits
We offer a competitive compensation and benefits package, tailored based on experience and location. At PhaseV, we believe in rewarding impact and fostering growth. You will be part of a mission-driven team, helping build a financial foundation that enables innovation and long-term success.